694
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Comparison of intermittent drainage of ascites and diuretic therapy for cirrhosis patients with tense ascites

, , , , , , , & ORCID Icon | (Reviewing Editor) show all
Article: 1340818 | Received 21 Feb 2017, Accepted 07 Jun 2017, Published online: 21 Jun 2017

References

  • European Association for the Study of the Liver. (2010). EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of Hepatology, 53, 397–417.
  • Fassio, E., Terg, R., Landeira, G., Abecasis, R., Salemne, M., Podesta, A., … Kravetz, D. (1992). Paracentesis with dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites: Results of a randomized study. Journal of Hepatology, 14, 310–316.10.1016/0168-8278(92)90176-P
  • Gines, A., Fernandez-Esparrach, G., Monescillo, A., Vila, C., Domenech, E., Abecasis, R., … Gines, P. (1996). Randomized controlled trial comparing albumin, dextran-70 and polygelin in cirrhotic patients with ascites treated by paracentesis. Gastroenterology, 111, 1002–1010.10.1016/S0016-5085(96)70068-9
  • Ginès, P., Quintero, E., Arroyo, V., Terés, J., Bruguera, M., Rimola, A., … Rozman, C. (1987). Compensated cirrhosis: Natural history and prognostic factors. Hepatology, 7, 122–128.10.1002/(ISSN)1527-3350
  • Ginès, P., Titó, L., Arroyo, V., Planas, R., Panés, J., Viver, J., … Badalamenti, S. (1988). Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology, 94, 1493–1502.10.1016/0016-5085(88)90691-9
  • Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. L., Castro, A. F., Feldman, H. I., … Coresh, J. (2009). A new equation to estimate glomerular filtration rate. Annals of Internal Medicine, 150, 604–612.10.7326/0003-4819-150-9-200905050-00006
  • Liaw, Y. F., Kao, J. H., Piratvisuth, T., Chan, H. L. Y., Chien, R. N., Liu, C. J., … Amarapurkar, D. (2012). Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update. Hepatology International, 6, 531–561.10.1007/s12072-012-9365-4
  • Liaw, Y. F., Leung, N., Kao, J. H., Piratvisuth, T., Gane, E., Han, K. H., … Locarnini, S. (2008). Asian-pacific consensus statement on the management of chronic hepatitis B: A 2008 update. Hepatology International, 2, 263–283.10.1007/s12072-008-9080-3
  • Liaw, Y. F., Sheen, I. S., Lee, C. M., Akarca, U. S., Papatheodoridis, G. V., Suet‐Hing Wong, F., … Buti, M. (2011). Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF and entecavir in patients with decompensated chronic hepatitis B liver disease. Hepatology, 53, 62–72.10.1002/hep.23952
  • Liaw, Y. F., Tai, D. I., Chu, C. M., & Chen, T. J. (1988). The development of cirrhosis in patients with chronic type B hepatitis: A prospective study. Hepatology, 8, 493–496.10.1002/(ISSN)1527-3350
  • Lin, S. M., Yu, M. L., Lee, C. M., Chien, R. N., Sheen, I. S., Chu, C. M., & Liaw, Y. F. (2007). Interferon therapy in HBeAg positive chronic hepatitis reduces cirrhosis and hepatocellular carcinoma. Journal of Hepatology, 46, 45–52.10.1016/j.jhep.2006.08.021
  • Moreau, R., & Lebrec, D. (1999). Management of patients with cirrhosis and ascites. Gastroentérologie Clinique Et Biologique, 23, 379–387.
  • Panos, M. Z., Moore, K., Vlavianos, P., Chambers, J. B., Anderson, J. V., Gimson, A. E., … Williams, R. (1990). Single, total paracentesis fortense ascites: Sequential hemodynamic changes and right atrial size. Hepatology, 11, 662–667.10.1002/(ISSN)1527-3350
  • Pozzi, M., Osculati, G., Boari, G., Serboli, P., Colombo, P., Lambrughi, C, … D’amico, P. (1994). Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites. Gastroenterology, 106, 709–719.10.1016/0016-5085(94)90706-4
  • Salerno, F., Badalamenti, S., Incerti, P., Tempini, S., Restelli, B., Bruno, S., … Roffi, L. (1987). Repeated paracentesis and i.v. albumin infusion to treat ‘‘tense ascites” in cirrhotic patients: A safe alternative therapy. Journal of Hepatology, 5, 102–108.10.1016/S0168-8278(87)80067-3
  • Schrier, R. W., Arroyo, V., Bernardi, M., Epstein, M., Henriksen, J. H., & Rodés, J. (1988). Peripheral arterial vasodilatation hypothesis. A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology, 8, 1151–1157.10.1002/(ISSN)1527-3350
  • Shao, L., Qin, X., & Jiang, L. (2007). Application of drainage with central venous catheterization set in hepatic cirrhosis patients with refractory ascites. Journal of Practical Diagnosis and Therapy, 21, 911–913.
  • Shim, J. H., Lee, H. C., Kim, K. M., Lim, Y. S., Chung, Y. H., Lee, Y. S., & Suh, D. J. (2010). Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis. Journal of Hepatology, 52, 176–182.10.1016/j.jhep.2009.11.007
  • Simon, D. M., McCain, J. R., Bonkovsky, H. L., Wells, J. O., Hartle, D. K., & Galambos, J. T. (1987). Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function. Hepatology, 7, 423–429.10.1002/(ISSN)1527-3350
  • Zeng, X., Lin, Y., & Xie, W.-f. (2011). Management of ascites caused by cirrhosis. Chinese Journal of Digestion, 25, 757–758.